[Ovid] Efficacy and Safety of Recaticimab in Patients With Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials With GRADE Assessment

ahmed-talkhan22 Post time 1 hour(s) ago | Show all posts |Read mode

This post will be closed automatically in 2026-11-01 20:10

Reward10points

journal：Cardiology in Review

Authors：Ahmed Talkhan; Amr M. Abou Elezz; Nermin Ezzat Borham; Ahmed Noureldeen Abbas; Habiba Tariq Saeed; Lamees Taman; Mazen Momtaz Shehata; Muhammad M. Elsharkawy; Mohamed Hamouda Elkasaby; William H. Frishman; Wilbert S. Aronow

Published date：--

DOI：10.1097/crd.0000000000001529

PDF link：https://www.ovid.com/10.1097/CRD.0000000000001529

Article link：https://doi.org/10.1097/crd.0000000000001529

Article Source：Ovid Technologies (Wolters Kluwer Health)。

Remark：

You can support us by donating, we would be very grateful.

Reply

Use magic Donate Report

All Reply0 Show all posts

Reply

ahmed-talkhan22 Lv.2

Junior Member

post
reply
points
40

[Ovid] Efficacy and Safety of Recaticimab in Patients With Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials With GRADE Assessment

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Ovid] Efficacy and Safety of Recaticimab in Patients With Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials With GRADE Assessment Copy

Reply

Same Category

Latest Reply

Announcement

Daily Top Contributors

[Ovid] Efficacy and Safety of Recaticimab in Patients With Dyslipidemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials With GRADE Assessment